{"DataElement":{"publicId":"6042214","version":"1","preferredName":"Radiation Therapy Dose Administered to 95% Planning Target Volume Value","preferredDefinition":"Number value of the dose of radiation given to 95% of the planned target volume.","longName":"RT_DS_95_PTV_VL","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"6041980","version":"1","preferredName":"Radiation Therapy Dose 95 Percent Unit Planning Target Volume Administered","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._A number with no fractional part, including the negative and positive numbers as well as zero.::95_A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred)._A geometrical concept defined to select appropriate beam arrangements, taking into consideration the net effect of all possible geometrical variations, in order to ensure that the prescribed dose is actually absorbed in the clinical target volume._The act of having given something (e.g., a medication or test).","longName":"2403872v1.0:6041978v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2403872","version":"1","preferredName":"Radiation Therapy","preferredDefinition":"use PHOTOTHERAPY, LASER THERAPY, or ULTRAVIOLET THERAPY for therapeutic radiation with visible, laser, or ultraviolet light, respectively.","longName":"C15313","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"004438C0-4DCB-6342-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-08","modifiedBy":"ONEDATA","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6041978","version":"1","preferredName":"Dose Integer::95 Percent Unit Planning Target Volume Administered","preferredDefinition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.:A number with no fractional part, including the negative and positive numbers as well as zero.::95:A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).:A geometrical concept defined to select appropriate beam arrangements, taking into consideration the net effect of all possible geometrical variations, in order to ensure that the prescribed dose is actually absorbed in the clinical target volume.:The act of having given something (e.g., a medication or test).","longName":"6041978v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Percent Unit","conceptCode":"C48570","definition":"A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Planning Target Volume","conceptCode":"C82606","definition":"A geometrical concept defined to select appropriate beam arrangements, taking into consideration the net effect of all possible geometrical variations, in order to ensure that the prescribed dose is actually absorbed in the clinical target volume.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6016FEB0-69E5-1E16-E053-F662850A77A7","latestVersionIndicator":"Yes","beginDate":"2017-12-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-12","modifiedBy":"ONEDATA","dateModified":"2017-12-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Princess Margaret Cancer Centre, Toronto, ON","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6016FEB0-69F6-1E16-E053-F662850A77A7","latestVersionIndicator":"Yes","beginDate":"2017-12-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-12","modifiedBy":"COOPERM","dateModified":"2017-12-15","changeDescription":"Created for Auditi request 11.14.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2199529","version":"1.1","preferredName":"Percentage Value","preferredDefinition":"A fraction or ratio with 100 understood as the denominator._A numerical quantity measured or assigned or computed.","longName":"PTG_VAL","context":"CCR","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03BC56FB-E71D-02CF-E050-BB89AD430891","latestVersionIndicator":"Yes","beginDate":"2014-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-09-23","modifiedBy":"REEVESD","dateModified":"2014-09-23","changeDescription":"VD v1.1 replaces v1.0 with a name change.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Dose to 95% PTV","type":"Preferred Question Text","description":"Dose to 95% PTV","url":null,"context":"NCIP"}],"origin":"Princess Margaret Cancer Centre, Toronto, ON","workflowStatus":"RELEASED","registrationStatus":"Application","id":"602D8F3F-8561-4BAE-E053-F662850A4475","latestVersionIndicator":"Yes","beginDate":"2017-12-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-12-12","modifiedBy":"COOPERM","dateModified":"2017-12-15","changeDescription":"Created for Auditi SBRT request 11.14.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}